
New immunotherapy targets leukemia at its root
Acute myeloid leukemia (AML) is one of the most aggressive

Acute myeloid leukemia (AML) is one of the most aggressive

Conventional gene-editing technologies, such as CRISPR Cas9, have been limited

Chimeric Antigen Receptor (CAR)-T cells have revolutionized cancer therapy, by

CAR-T cell therapy is one of the most promising cancer

A recent clinical trial published in Nature has demonstrated promising

Researchers have introduced a next-generation CAR T-cell therapy, called EchoBack

One of the functions of Natural Killer (NK) cells is

Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized cancer treatment

Neuroblastoma, a highly aggressive childhood cancer, presents a high risk
Cookies
We use audience measurement cookies (Google Analytics) to improve this website. They are only set with your consent. You can change your mind at any time via “Cookie settings” at the bottom of the page. Privacy & Cookies Policy